404 related articles for article (PubMed ID: 8866570)
21. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains.
Jones HB; Nugent D; Jenkins R
Int J Exp Pathol; 2010 Jun; 91(3):288-301. PubMed ID: 20384904
[TBL] [Abstract][Full Text] [Related]
22. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
Pick A; Clark J; Kubstrup C; Levisetti M; Pugh W; Bonner-Weir S; Polonsky KS
Diabetes; 1998 Mar; 47(3):358-64. PubMed ID: 9519740
[TBL] [Abstract][Full Text] [Related]
23. Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis.
Parton LE; McMillen PJ; Shen Y; Docherty E; Sharpe E; Diraison F; Briscoe CP; Rutter GA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E982-94. PubMed ID: 16772326
[TBL] [Abstract][Full Text] [Related]
24. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
25. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes.
Hirose H; Lee YH; Inman LR; Nagasawa Y; Johnson JH; Unger RH
J Biol Chem; 1996 Mar; 271(10):5633-7. PubMed ID: 8621426
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion.
MacDonald MJ
J Biol Chem; 1995 Aug; 270(34):20051-8. PubMed ID: 7650022
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats.
Wu L; Yang W; Jia X; Yang G; Duridanova D; Cao K; Wang R
Lab Invest; 2009 Jan; 89(1):59-67. PubMed ID: 19002107
[TBL] [Abstract][Full Text] [Related]
28. DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.
Byrne JJ; Bradlow HL
Diabetes Technol Ther; 2001; 3(2):211-9. PubMed ID: 11478327
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic islet mitochondrial glycerophosphate dehydrogenase deficiency in two animal models of non-insulin-dependent diabetes mellitus.
Fabregat ME; Novials A; Giroix MH; Sener A; Gomis R; Malaisse WJ
Biochem Biophys Res Commun; 1996 Mar; 220(3):1020-3. PubMed ID: 8607784
[TBL] [Abstract][Full Text] [Related]
30. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes.
Li X; Zhang L; Meshinchi S; Dias-Leme C; Raffin D; Johnson JD; Treutelaar MK; Burant CF
Diabetes; 2006 Nov; 55(11):2965-73. PubMed ID: 17065332
[TBL] [Abstract][Full Text] [Related]
31. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
32. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats.
Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK
Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003
[TBL] [Abstract][Full Text] [Related]
33. Fibre type distribution and gene expression levels of both succinate dehydrogenase and peroxisome proliferator-activated receptor-gamma coactivator-1alpha of fibres in the soleus muscle of Zucker diabetic fatty rats.
Adachi T; Kikuchi N; Yasuda K; Anahara R; Gu N; Matsunaga T; Yamamura T; Mori C; Tsujimoto G; Tsuda K; Ishihara A
Exp Physiol; 2007 Mar; 92(2):449-55. PubMed ID: 17158179
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats.
Zhou YP; Ostenson CG; Ling ZC; Grill V
Endocrinology; 1995 Aug; 136(8):3546-51. PubMed ID: 7628391
[TBL] [Abstract][Full Text] [Related]
35. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats.
Alemzadeh R; Tushaus K
Med Sci Monit; 2005 Dec; 11(12):BR439-48. PubMed ID: 16319780
[TBL] [Abstract][Full Text] [Related]
36. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
[TBL] [Abstract][Full Text] [Related]
37. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.
Lee Y; Hirose H; Zhou YT; Esser V; McGarry JD; Unger RH
Diabetes; 1997 Mar; 46(3):408-13. PubMed ID: 9032096
[TBL] [Abstract][Full Text] [Related]
38. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat.
Sturis J; Pugh WL; Tang J; Ostrega DM; Polonsky JS; Polonsky KS
Am J Physiol; 1994 Aug; 267(2 Pt 1):E250-9. PubMed ID: 8074204
[TBL] [Abstract][Full Text] [Related]
39. Oscillations in activities of enzymes in pancreatic islet subcellular fractions induced by physiological concentrations of effectors.
MacDonald MJ; Al-Masri H; Jumelle-Laclau M; Cruz MO
Diabetes; 1997 Dec; 46(12):1996-2001. PubMed ID: 9392486
[TBL] [Abstract][Full Text] [Related]
40. Progressive histopathological changes in pancreatic islets of Zucker Diabetic Fatty rats.
Janssen SW; Hermus AR; Lange WP; Knijnenburg Q; van der Laak JA; Sweep CG; Martens GJ; Verhofstad AA
Exp Clin Endocrinol Diabetes; 2001; 109(5):273-82. PubMed ID: 11507651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
